Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.86 |
| ▸ | NQO2 | P16083 | 5/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | MYC | P01106 | 1/20 | 0.53 |
| ▸ | MAX | P61244 | 1/20 | 0.53 |
| ▸ | METAP2 | P50579 | 2/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | COMT | P21964 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | METAP1 | P53582 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20475303 | 0.98 | ALDH1A1 (0.95) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL3181469 | 0.93 | ACHE (1.00) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL13439504 | 0.90 | ACHE (0.85) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL18387564 | 0.87 | ALDH1A1 (0.77) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL3244933 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL31011404 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL3728001 | 0.84 | ALDH1A1 (0.71) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL762952 | 0.83 | ACHE (0.72) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL20272058 | 0.81 | ACHE (0.69) | ALDH1A1MAPTRAB9AGAAKMT2A | |
| SCHEMBL18387448 | 0.81 | NQO2 (1.00) | ALDH1A1MAPTRAB9AGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051299-A | Method for recovering capacity of water system organic flow battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | claimed |
| US-20260091089-A1 | Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria | CALIFORNIA INST OF TECHN (US) | 2026-04-02 | — | — | US | claimed |
| US-20250341489-A1 | AN ELECTROCHEMICAL SENSOR AND METHOD FOR DETECTING PATHOGENIC METABOLITES | DURHAM UNIVERSITY (GB) | 2025-11-06 | — | — | US | claimed |
| US-12444759-B1 | Ultra-high stability phenazine-based electrolyte for alkaline aqueous organic redox flow battery (AORFB), and flow battery | SUZHOU LABORATORY (CN) | 2025-10-14 | — | — | US | claimed |
| US-12427188-B2 | Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-09-30 | — | — | US | claimed |
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-07-17 | — | — | US | claimed |
| CN-119874764-A | Phenazine vanadium compound and method for synthesizing cycloalkyl alcohol and cycloalkyl ketone by selective catalytic oxidation of cycloalkane | 中国石油化工股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-4533076-A1 | AN ELECTROCHEMICAL SENSOR AND METHOD FOR DETECTING PATHOGENIC METABOLITES | University of Durham (GB) | 2025-04-09 | — | — | EP | claimed |
| CN-115656379-B | Extraction method of phthalate and polycyclic aromatic hydrocarbon in blood | 遵义医科大学 | 2025-03-25 | — | — | CN | claimed |
| CN-118867328-B | Super-stability phenazine alkaline aqueous organic flow battery electrolyte and flow battery | 苏州实验室 | 2025-02-07 | — | — | CN | claimed |
| EP-1558585-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | Prana Biotechnology Ltd (AU) | 2005-08-03 | — | — | EP | claimed |
| WO-2004031161-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | PRANA BIOTECHNOLOGY LIMITED (AU) | 2004-04-15 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0830709-B1 | ELECTROLYTE MATERIALS CONTAINING HIGHLY DISSOCIATED METAL ION SALTS | MOLTECH CORP (US) | 2001-07-04 | — | — | EP | claimed |
| US-5837390-A | Metal complex, method for producing the same and optical device | SONY CORPORATION (JP) | 1998-11-17 | — | — | US | claimed |
| WO-1996029753-A9 | ELECTROLYTE MATERIALS CONTAINING HIGHLY DISSOCIATED METAL ION SALTS | — | 1997-01-16 | — | — | WO | claimed |
| WO-1996029753-A1 | ELECTROLYTE MATERIALS CONTAINING HIGHLY DISSOCIATED METAL ION SALTS | MOLTECH CORPORATION (US) | 1996-09-26 | — | — | WO | claimed |
| US-5538812-A | ELECTROLYTIC CELLS WITH POLYETHERSILOXANES WITH GROUPS OF TRIFLUOROMETHANESULFONYL | MOLTECH CORPORATION (US) | 1996-07-23 | — | — | US | claimed |
| EP-0502964-B1 | USE OF COMPLEX LIGANDS FOR IONS IN FERROELECTRIC LIQUID CRYSTAL MIXTURES | HOECHST AG (DE) | 1995-02-22 | — | — | EP | claimed |
| EP-0377357-B1 | Process for the condensation of at least one epoxide on at least one cyclic anhyhride in the presence of a titanium-based catalyst | INST FRANCAIS DU PETROLE (FR) | 1994-03-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | ALDH1A1 720/4885MAPT 2622/4885RAB9A 2637/4885 |
| US-12427188-B2 | Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria | KDM5C, KDM5A, KDM3A | ALDH1A1 1384/4885MAPT 3647/4885RAB9A 1699/4885 |
| US-20260091089-A1 | Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria | KDM5C, KDM5A, KDM1B | ALDH1A1 1630/4885MAPT 4612/4885RAB9A 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.